Drug
Valganciclovir
Valganciclovir: highest development phase Post-Market, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Valganciclovir NCT01509404 | Post-Market | Cytomegalovirus Disease |
Latest
No recent events.
Follow Valganciclovir on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.